Hyperbaric Oxygen (HBO2) Therapy

There is general agreement among the three guideline developers that HBO2 therapy may be an appropriate adjuvant intervention for selected patients. IWGDF makes a weak recommendation on the basis of moderate-quality evidence for the consideration of systemic HBO2 therapy in order to accelerate healing of DFUs. Further blinded and randomized trials are required to confirm [...]

By | 2017-08-10T15:37:44+00:00 June 24th, 2017|News, Oxygen Observer|0 Comments

Are You Reporting Quality Metrics?

In October 2016, the Department of Health and Human Services (HHS) issued its final rule implementing the Quality Payment Program that is part of MACRA (Medicare Access and CHIP Reauthorization Act) which had bipartisan support and approval of congress.  The purpose is to provide new tools and resources to patient and deliver best possible highest [...]

By | 2017-06-02T20:48:00+00:00 June 2nd, 2017|Uncategorized|0 Comments